The Role of Cardiopulmonary Exercise Testing (CPET) in Pulmonary Rehabilitation (PR) of Chronic Obstructive Pulmonary Disease (COPD) Patients

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 15, Issue 6, 2018, Pages 621-631

  Stringer, William ^a   Marciniuk, Darcy ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

cardiopulmonary exercise testing; Chronic obstructive pulmonary disease; pulmonary rehabilitation

Indexed keywords

CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; EXERCISE INTENSITY; FUNCTIONAL STATUS; HUMAN; INFLAMMATORY DISEASE; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; SOCIAL INTERACTION; STRATIFICATION; EXERCISE; EXERCISE TOLERANCE; KINESIOTHERAPY; PATHOPHYSIOLOGY; PATIENT SAFETY; PHYSIOLOGY; RISK ASSESSMENT; WALK TEST;

EXERCISE; EXERCISE THERAPY; EXERCISE TOLERANCE; HUMANS; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; PATIENT SAFETY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; WALK TEST;

EID: 85063201354     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412555.2018.1550476     Document Type: Review

References (58)

1. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13–64.
2. Wasserman K, Hansen JE, Sue DY, Stringer WW, Sietsema KE, Sun XG, Whipp BJ. Principles of exercise testing and interpretation: including pathophysiology and clinical applications. 5th ed. Philadelphia, USA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011, 572 p.
3. Butcher SJ, Lagerquist O, Marciniuk DD, Petersen SR, Collins DF, Jones RL. Relationship between ventilatory constraint and muscle fatigue during exercise in COPD. Eur Respir J. 2009;33:763–770 doi: 10.1183/09031936.00014708.
4. Casaburi R, ZuWallack R. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med 2009;360:1329–1335 doi: 10.1056/NEJMct0804632.
5. Porszasz J, Emtner M, Goto S, Somfay A, Whipp BJ, Casaburi R. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005;128:2025–2034
6. Ma S, Hecht A, Varga J, Rambod M, Morford S, Goto S, Casaburi R, Porszasz J. Breath-by-breath quantification of progressive airflow limitation during exercise in COPD: a new method. Respir Med 2010;104:389–396 doi: 10.1016/j.rmed.2009.10.014.
7. Varga J, Casaburi R, Ma S, Hecht A, Hsia D, Somfay A, Porszasz J. Relation of concavity in the expiratory flow-volume loop to dynamic hyperinflation during exercise in COPD. Respir Physiol Neurobiol 2016;234:79–84
8. Porszasz J, Carraro N, Cao R, Gore A, Ma S, Jiang T, Maltais F, Ferguson GT, O’Donnell DE, Shaikh A. Effect of tiotropium on spontaneous expiratory flow–volume curves during exercise in GOLD 1-2 COPD. Resp Physiol Neurobiol 2018;251:8–15 doi: 10.1016/j.resp.2018.02.006.
9. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005–1012 doi: 10.1056/NEJMoa021322.
10. Garvey C, Bayles MP, Hamm LF, Hill K, Holland A, Limberg TM, Spruit MA. Pulmonary rehabilitation exercise prescription in chronic obstructive pulmonary disease: review of selected guidelines: an official statement from the American Association of Cardiovascular and Pulmonary Rehabilitation. J Cardiopulm Rehabil Prev. 2016;36:75–83 doi: 10.1097/HCR.0000000000000171.
11. Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, Dekhuijzen PN, Franssen F, Gayan-Ramirez G, Gea J, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189:e15–62
12. Marciniuk DD, Brooks D, Butcher S, Debigare R, Dechman G, Ford G, Pepin V, Reid D, Sheel AW, Stickland MK, et al. Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease–practical issues: a Canadian Thoracic Society Clinical Practice Guideline. Can Respir J 2010;17:159–168 doi: 10.1155/2010/425975.
13. Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, Ford G, Bourbeau J, O'Donnell DE, Maltais F, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011;18:69–78 doi: 10.1155/2011/745047.
14. Moore E, Newson R, Joshi M, Palmer T, Rothnie KJ, Singh S, Majeed A, Soljak M, Quint JK. Effects of pulmonary rehabilitation on exacerbation number and severity in people with COPD: an historical cohort study using electronic health records. Chest 2017;152:1188–1202
15. Moore E, Palmer T, Newson R, Majeed A, Quint JK, Soljak MA. Pulmonary rehabilitation as a mechanism to reduce hospitalizations for acute exacerbations of COPD: a systematic review and meta-analysis. Chest 2016;150:837–859
16. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173:1390–1413 doi: 10.1164/rccm.200508-1211ST.
17. Rehabilitation BTSSoCSoP. Pulmonary rehabilitation. Thorax 2001;56:827–834
18. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 2007;131:4S–42S
19. Rochester CL, Vogiatzis I, Holland AE, Lareau SC, Marciniuk DD, Puhan MA, Spruit MA, Masefield S, Casaburi R, Clini EM, et al. An official American Thoracic Society/European Respiratory Society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation. Am J Respir Crit Care Med. 2015;192:1373–1386 doi: 10.1164/rccm.201510-1966ST.
20. Troosters T, Casaburi R, Gosselink R, Decramer M. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:19–38 doi: 10.1164/rccm.200408-1109SO.
21. Laboratories ACoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117
22. Salzman SH. The 6-min walk test: clinical and research role, technique, coding, and reimbursement. Chest 2009;135:1345–1352
23. Cote CG, Pinto-Plata V, Kasprzyk K, Dordelly LJ, Celli BR. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 2007;132:1778–1785
24. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;4:CD003793
25. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis. 1991;143:9–18
26. Rossi A, Aisanov Z, Avdeev S, Di Maria G, Donner CF, Izquierdo JL, Roche N, Similowski T, Watz H, Worth H, et al. Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med. 2015;109:785–802
27. Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med. 2003;168:1034–1042 doi: 10.1164/rccm.200212-1525OC.
28. Puente-Maestu L, Palange P, Casaburi R, Laveneziana P, Maltais F, Neder JA, O'Donnell DE, Onorati P, Porszasz J, Rabinovich R, et al. Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J. 2016;47:429–460
29. ATS/ACCP. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211–277
30. Lareau SC, ZuWallack R, Carlin B, Celli B, Fahy B, Gosselink R, Jones P, Larson JL, Meek P, Rochester C, et al. Pulmonary rehabilitation-1999. American Thoracic Society. Am J Respir Crit Care Med. 1999;159:1666–1682
31. Bernard S, Whittom F, Leblanc P, Jobin J, Belleau R, Bérubé C, Carrier G, Maltais F. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:896–901 doi: 10.1164/ajrccm.159.3.9807034.
32. O'Donnell DE, McGuire M, Samis L, Webb KA. General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation. Am J Respir Crit Care Med. 1998;157:1489–1497 doi: 10.1164/ajrccm.157.5.9708010.
33. Troosters T, Gosselink R, Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med. 2000;109:207–212 doi: 10.1016/S0002-9343(00)00472-1.
34. Andersen P, Henriksson J. Training induced changes in the subgroups of human type II skeletal muscle fibres. Acta Physiol Scand. 1977;99:123–125
35. Maltais F, LeBlanc P, Jobin J, Bérubé C, Bruneau J, Carrier L, Breton MJ, Falardeau G, Belleau R. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997;155:555–561 doi: 10.1164/ajrccm.155.2.9032194.
36. Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med. 2014;189:250–255 doi: 10.1164/rccm.201310-1863PP.
37. Man-Son-Hing M, Laupacis A, O'Rourke K, Molnar FJ, Mahon J, Chan KB, Wells G. Determination of the clinical importance of study results. J Gen Intern Med. 2002;17:469–476
38. Boschetto P, Beghé B, Fabbri LM, Ceconi C. Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice. Respirology 2012;17:422–431 doi: 10.1111/j.1440-1843.2011.02118.x.
39. Casaburi R, Kukafka D, Cooper CB, Witek TJ, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005;127:809–817
40. Chavoshan B, Fournier M, Lewis MI, Porszasz J, Storer TW, Da X, Rambod M, Casaburi R. Testosterone and resistance training effects on muscle nitric oxide synthase isoforms in COPD men. Respir Med. 2012;106:269–275 doi: 10.1016/j.rmed.2011.07.018.
41. Evans RA, Dolmage TE, Mangovski-Alzamora S, Romano J, O'Brien L, Brooks D, Goldstein RS. One-legged cycle training for chronic obstructive pulmonary disease. A pragmatic study of implementation to pulmonary rehabilitation. Ann Am Thorac Soc. 2015;12:1490–1497 doi: 10.1513/AnnalsATS.201504-231OC.
42. Marciniuk DD, Butcher SJ, Reid JK, MacDonald GF, Eves ND, Clemens R, Jones RL. The effects of helium-hyperoxia on 6-min walking distance in COPD: a randomized, controlled trial. Chest 2007;131:1659–1665
43. Geiger S, Hirsch D, Hermann FG. Cell therapy for lung disease. Eur Respir Rev. 2017;26:170044
44. Oh DK, Kim YS, Oh YM. Lung regeneration therapy for chronic obstructive pulmonary disease. Tuberc Respir Dis (Seoul). 2017;80:1–10
45. Sun Z, Li F, Zhou X, Chung KF, Wang W, Wang J. Stem cell therapies for chronic obstructive pulmonary disease: current status of pre-clinical studies and clinical trials. J Thorac Dis. 2018;10:1084–1098 doi: 10.21037/jtd.2018.01.46.
46. Wecht S, Rojas M. Mesenchymal stem cells in the treatment of chronic lung disease. Respirology 2016;21:1366–1375
47. Casaburi R, Porszasz J, Burns MR, Carithers ER, Chang RS, Cooper CB. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997;155:1541–1551 doi: 10.1164/ajrccm.155.5.9154855.
48. Donohue JF. Minimal clinically important differences in COPD lung function. COPD 2005;2:111–124
49. Mahler DA, Witek TJ. The MCID of the transition dyspnea index is a total score of one unit. COPD 2005;2:99–103
50. Ries AL. Minimally clinically important difference for the UCSD shortness of breath questionnaire, Borg scale, and visual analog scale. COPD 2005;2:105–110
51. Jones PW. St. George's respiratory questionnaire: MCID. COPD 2005;2:75–79
52. Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, Wise RA, Sciurba F, Group NETTNR. The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011;37:784–790 doi: 10.1183/09031936.00063810.
53. Cazzola M, MacNee W, Martinez FJ, Rabe KF. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Rev Port Pneumol. 2008;14:579–583 doi: 10.1016/S0873-2159(15)30266-X.
54. Wasserman K, Hansen JE, Sue DY, Stringer WW, Sietsema K, S. X-G, Whipp BJ. Principles of exercise testing and interpretation: pathophysiology and clinical applications. Baltimore, Maryland: Lippincott Williams & Wilkins; 2012
55. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179–187
56. Castellsague J, Burgos F, Sunyer J, Barbera JA, Roca J. Prediction equations for forced spirometry from European origin populations. Barcelona Collaborative Group on Reference Values for Pulmonary Function Testing and the Spanish Group of the European Community Respiratory Health Survey. Respir Med. 1998;92:401–407 doi: 10.1016/S0954-6111(98)90282-7.
57. Miller A, Thornton JC, Warshaw R, Anderson H, Teirstein AS, Selikoff IJ. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis. 1983;127:270–277
58. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol. 1986;60:2020–2027